ClinicalTrials.Veeva

Menu

Endobronchial Diagnosis of Lymphoma (EnDol)

C

Caen University Hospital

Status

Unknown

Conditions

Lymphoma

Treatments

Device: Endobronchial ultrasound guided miniforceps biopsy and transbronchial needle aspiration

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The present study aimed to assess the diagnostic performance of ultrasound-guided endobronchial intra-nodal miniforceps biopsy (EBUS-MFB) in the diagnosis of "de novo" mediastinal lymphoma.

Full description

Every patients will be sampled using both EBUS-MFB and the standard of care EBUS-TBNA (transbronchial needle aspiration).

It is a monocentric investigation. Pathologist will not know the way of sampling while analysing the samples

Enrollment

33 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pathological mediastinal nodes within reach of EBUS sampling on CT-scan.
  • Lymphoma suspicion by a senior clinical hematologist
  • Affiliated to the french public health care insurance

Exclusion criteria

  • Peripherical pathological lymph nodes reachable without general anesthesia
  • Antithrombotic medication that cannot be stopped le time of the procedure.
  • Unstable respiratory status
  • History of lymphoma
  • Latex or xylocaine allergia

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Sequential Assignment

Masking

None (Open label)

33 participants in 1 patient group

EBUS-MFB and EBUS-TBNA
Experimental group
Description:
patient will have both TBNA and MFB in the same operating time
Treatment:
Device: Endobronchial ultrasound guided miniforceps biopsy and transbronchial needle aspiration

Trial contacts and locations

1

Loading...

Central trial contact

Pierre M Cuchet, MD; Romain M Magnier, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems